Paradigm Therapeutics, Inc.
PrivateLast Round
VC Round
Jun 18, 2025
Company Overview
Paradigm Therapeutics, Inc. is a biopharmaceutical company that develops innovative topical therapies for the treatment of rare diseases, specifically Epidermolysis Bullosa.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradigm Therapeutics, Inc. Comparables
Compare Paradigm Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mariposa Therapeutics | 43% | |
| Aegle Therapeutics Corp | 38% | |
Paradigm Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2025 | ||||
| VC Round | May 6, 2025 |
Key People
Founding team and executive leadership
Paradigm Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eshelman Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2025
$13M round led by Eshelman Ventures.
- May 6, 2025
$13M round led by Eshelman Ventures
Paradigm Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paradigm Therapeutics, Inc.'s valuation, stock price, and market status.